Sio Capital Management’s Bicycle Therapeutics BCYC Stock Holding History

Sio Capital Management’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-796,933	Closed	-$16M	–	45
2023 Q3	$16M	Sell	796,933 -171,738	-18%	-$3.93M	4.96%	7
2023 Q2	$24.7M	Buy	968,671 +1,324	+0.1%	+$30.8K	6.29%	5
2023 Q1	$20.6M	Buy	967,347 +283,922	+42%	+$7.12M	10.17%	3
2022 Q4	$20.2M	Hold	683,425	–	–	7.48%	3
2022 Q3	$15.9M	Sell	683,425 -5,564	-0.8%	-$132K	5.05%	7
2022 Q2	$11.6M	Buy	688,989 +636,201	+1,205%	+$13.4M	4.34%	6
2022 Q1	$2.32M	Sell	52,788 -1,212	-2%	-$56.6K	0.77%	33
2021 Q4	$3.29M	Buy	+54,000	New	+$2.98M	0.99%	27

Other funds holding BCYC

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Sio Capital Management's BCYC Position: Q4 2023 in Review

Sio Capital Management sold out of Bicycle Therapeutics (BCYC) in Q4 2023, closing a stake of 796,933 shares — an estimated $16M sold.

Sio Capital Management first reported a position in BCYC in Q4 2021 and held it in 8 quarters. The position peaked at $24.7M in Q2 2023. 101 funds tracked by Wall St. Rank hold BCYC as of Q4 2023.

Sio Capital Management reported no remaining Bicycle Therapeutics position as of Q4 2023 after selling out during the quarter.
Sio Capital Management sold 796,933 Bicycle Therapeutics shares in Q4 2023, an estimated $16M.
Sio Capital Management first reported a position in Bicycle Therapeutics in Q4 2021 and held it in 8 quarters.
Sio Capital Management's Bicycle Therapeutics position peaked at $24.7M in Q2 2023.
101 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2023.

Based on Sio Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.